RT Journal Article
SR Electronic
T1 <em>Wolbachia</em>-mediated sterility suppresses <em>Aedes aegypti</em> populations in the urban tropics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.16.21257922
DO 10.1101/2021.06.16.21257922
A1 The Project Wolbachia – Singapore Consortium
A1 Ching, Ng Lee
YR 2021
UL http://medrxiv.org/content/early/2021/06/17/2021.06.16.21257922.abstract
AB Incompatible insect technique (IIT) via releases of male Wolbachia-infected mosquitoes is a promising tool for dengue control. In a three-year trial in Singaporean high-rise housing estates, we demonstrated that Wolbachia-based IIT dramatically reduces both wildtype Aedes aegypti populations [reductions of 92.7% (95% CI: 84.7%–95.8%) and 98.3% (97.7%–99.8%)] and dengue incidence [reductions of 71% (43%-87%) to 88% (57%-99%)] in the targeted areas. The study highlights the need to ensure adequate vertical distribution of released males in high-rise buildings, address immigration of wildtype females from neighboring areas, and prevent and mitigate stable establishment of Wolbachia in field mosquito populations. Our results demonstrate the potential of Wolbachia-based IIT (supplemented with irradiation, in Singapore’s context) for strengthening dengue control in tropical cities, where dengue burden is the greatest.One Sentence Summary Releases of male Wolbachia-infected Aedes aegypti suppress dengue mosquitoes and reduce dengue incidence in high-rise urban areas in Singapore.Competing Interest StatementBJW, EGK, YY, BH, NS, and LU were paid employees of Verily Life Sciences, a for-profit company developing products for mosquito control, at the time they performed research for this study.Funding StatementThis study was supported by funding from Singapore's Ministry of Finance, Ministry of Sustainability and the Environment, National Environment Agency, and National Robotics Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Each phase of the pilot project was reviewed and approved by the management of the National Environment Agency, the management of the Ministry of Sustainability and the Environment (previously known as the Ministry of the Environment and Water Resources), and the Minister for Sustainability and the Environment (previously known as the Minister for the Environment and Water Resources). The project was exempted from formal bioethics review as it is not considered human biological research, as advised by the Ministry of Health, and was an operational pilot study. This study is not a clinical trial, as the primary research question was to assess the impact of Wolbachia on entomological measures. The evaluation of the effect on dengue incidence was a retrospective secondary analysis using national dengue surveillance data collected by the Ministry of Health. Permission to use anonymised dengue case data was obtained from the Ministry of Health.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the main text or the supplementary materials.